Grifols, S.A.

Grifols, S.A.verified

GRFS

Price:

$7.64

Market Cap:

$6.15B

Grifols, S.A., a company founded in 1940 and headquartered in Barcelona, Spain, specializes in the development, manufacture, and distribution of therapeutic products, with a primary focus on those derived from human plasma. Its operations are organized into several divisions. The Bioscience division is dedicated to researching, producing, and marketing plasma-derived medicines, such as immunoglobulins, alpha-1 antitrypsin, albumin, and clotting factors, along with other innovative treatments for chronic, rare, prevalent, and life-threatening conditions. The Hospital division provides non-biological pharmaceuticals, medical supplies, clinical nutrition solutions, intravenous therapies, and me...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2011-06-02

Stock Exchange

NASDAQ

Ticker

GRFS

The Enterprise Value as of June 2026 (TTM) for Grifols, S.A. (GRFS) is 15.12B

According to Grifols, S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.12B. This represents a change of 8.99% compared to the average of 13.87B of the last 4 quarters.

Grifols, S.A. (GRFS) Historical Enterprise Value (quarterly & annually)

How has GRFS Enterprise Value performed in the past?

The mean historical Enterprise Value of Grifols, S.A. over the last ten years is 19.75B. The current 15.12B Enterprise Value has changed 7.55% with respect to the historical average. Over the past ten years (40 quarters), GRFS's Enterprise Value was at its highest in in the December 2019 quarter at 28.06B. The Enterprise Value was at its lowest in in the September 2022 quarter at 0.

Quarterly (TTM)
Annual

Average

19.75B

Median

20.10B

Minimum

15.28B

Maximum

27.90B

Grifols, S.A. (GRFS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Grifols, S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 34.92%

Maximum Annual Enterprise Value = 27.90B

Minimum Annual Increase = -23.70%

Minimum Annual Enterprise Value = 15.28B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202515.28B-0.34%
202415.33B-23.70%
202320.09B21.67%
202216.51B-17.96%
202120.12B-11.27%
202022.68B-18.71%
201927.90B34.92%
201820.68B-6.00%
201722.00B30.24%
201616.89B-7.34%

Grifols, S.A. (GRFS) Average Enterprise Value

How has GRFS Enterprise Value performed in the past?

The current Enterprise Value of Grifols, S.A. (GRFS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

16.90B

5-year avg

17.46B

10-year avg

19.75B

Grifols, S.A. (GRFS) Enterprise Value vs. Peers

How is GRFS’s Enterprise Value compared to its peers?

Grifols, S.A.’s Enterprise Value is greater than Henry Schein, Inc. (12.87B), greater than Halozyme Therapeutics, Inc. (10.08B), greater than Molina Healthcare, Inc. (9.07B), greater than AptarGroup, Inc. (8.70B), greater than Globus Medical, Inc. (10.40B), less than DaVita Inc. (25.89B), greater than Bio-Rad Laboratories, Inc. (8.60B), greater than Avantor, Inc. (9.95B), greater than Masimo Corporation (9.78B), greater than Corcept Therapeutics Incorporated (8.80B),

Build a custom stock screener for Grifols, S.A. (GRFS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grifols, S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Grifols, S.A. (GRFS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Grifols, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Grifols, S.A.'s Enterprise Value?

What is the highest Enterprise Value for Grifols, S.A. (GRFS)?

What is the 3-year average Enterprise Value for Grifols, S.A. (GRFS)?

What is the 5-year average Enterprise Value for Grifols, S.A. (GRFS)?

How does the current Enterprise Value for Grifols, S.A. (GRFS) compare to its historical average?